A newly-released report from Pharmaceutical Research and Manufacturers of America (PhRMA) has revealed that 28 new medications are in development to treat epilepsy and seizures.
But that’s just the tip of the iceberg.
These 28 new drugs are among nearly 420 new ground-breaking medicines in progress to treat neurological disorders.
There are 200,000 new cases of epilepsy each year, and a total of more than 3 million Americans are affected by it.
Yet, public and private funding for epilepsy research lags far behind other neurological afflictions, at $35 a patient (compared, for instance, with $129 for Alzheimer’s and $280 for multiple sclerosis).